Company Overview of Tivorsan Pharmaceuticals, Inc
Tivorsan Pharmaceuticals, Inc develops protein therapeutics for the treatment of neuromuscular disorders, including Duchenne muscular dystrophy and Becker muscular dystrophy. The company was founded in 2008 and is based in Providence, Rhode Island.
3 Davol Square
Providence, RI 02903
Founded in 2008
Key Executives for Tivorsan Pharmaceuticals, Inc
Tivorsan Pharmaceuticals, Inc Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Tivorsan Pharmaceuticals, Inc, please visit www.tivorsan.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.